When was Amydis Diagnostics founded?

Amydis Diagnostics was founded in 2013 and raised its 1st funding round 2 years after it was founded.

Where is Amydis Diagnostics located?

Amydis Diagnostics is headquartered in San Diego, United States.

Who is the current CEO of Amydis Diagnostics?

Stella Sarraf of Amydis Diagnostics.

How many employees does Amydis Diagnostics have?

As of Jul 31, 2026, the latest employee count at Amydis Diagnostics is 12.

Is Amydis Diagnostics a funded company?

Amydis Diagnostics is a funded company, having raised a total of $8.69M across 15 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 29, 2015.

When was the latest funding round of Amydis Diagnostics?

Amydis Diagnostics' latest funding was a $***** Grant (prize money) round on Sep 09, 2025, with participation from 1 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $4.05B in funding in 2026 to date.

Where does Amydis Diagnostics rank among its competitors?

Amydis Diagnostics ranks 4th amongst 46 active competitors, of which 18 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was ALZpath, which secured $8.41M in Jul, 2026.

Who are the top competitors of Amydis Diagnostics?

Amydis Diagnostics' top competitors include NeuroDex, C₂N Diagnostics and ALZpath. Among them, ALZpath secured the most recent funding round in July, 2026.

Amydis Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Amydis Diagnostics is a series A company based in San Diego (United States), founded in 2013 by Stella Sarraf. It operates as a Developer of diagnostics test for detection of Alzheimer's disease. Amydis Diagnostics has raised $8.69M in funding. The company has 46 active competitors, including 18 funded and 2 that have exited. Its top competitors include companies like NeuroDex, C₂N Diagnostics and ALZpath.

Company Details

Developer of diagnostics test for detection of Alzheimer's disease. The company is developing a novel family of fluorescent probes to be used as diagnostic agents to image neurodegenerative diseases through an ophthalmic approach using standard technology available in eye care specialist offices.

Key Metrics

Founded Year

2013

Location

San Diego, United States

Stage

Series A

Total Funding

$8.69M in 15 rounds

Latest Funding Round

Grant (prize money), Sep 09, 2025, $*****

Investors

NIA & 5 more

Ranked

4^th among 46 active competitors

Employee Count

12 as on Jul 31, 2026

Similar Companies

NeuroDex & 59 more

View Amydis Diagnostics' full profile

Amydis Diagnostics has raised a total funding of $8.69M over 15 rounds. Its first funding round was on Sep 29, 2015. Its latest funding round was a Grant (prize money) round on Sep 09, 2025 for $*****. 1 investor participated in its latest round. Amydis Diagnostics has 6 institutional investors.

Here is the list of recent funding rounds of Amydis Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 09, 2025	4300373	Grant (prize money)	2373652	1077828	2235190	4093921
Dec 14, 2023	9889385	Series A	5304545	6189828	8202832	7057436
Aug 18, 2022	6699476	Grant (prize money)	9558356	1358994	2126003	NIH

Access funding benchmarks and valuations. Sign up today!

View details of Amydis Diagnostics's funding rounds and investors

The founders of Amydis Diagnostics is Stella Sarraf.

Here are the details of Amydis Diagnostics' key team members:

Stella Sarraf: CEO and Founder of Amydis Diagnostics.
Contact Info: 1 email address

View details of Amydis Diagnostics's Founder profiles and Board Members

Amydis Diagnostics' employee count trend

Amydis Diagnostics has 12 employees as of Jul 26. Here is Amydis Diagnostics's employee count trend over the years:

Employee count trend for Amydis Diagnostics

Uncover Amydis Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Amydis Diagnostics include NeuroDex, C₂N Diagnostics and ALZpath. Here is the list of Top 10 competitors of Amydis Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NeuroDex 2018, Natick (United States), Seed	Manufacturer of diagnostic tools for Alzheimer's disease	$1.36M	ICV, Military Health & 1 others	58/100
2nd	C₂N Diagnostics 2007, St. Louis (United States), Series B	Developer of diagnostics and therapies for Alzheimer's disease	$35M	Eisai, Samsung Venture Investment & 6 others	58/100
3rd	ALZpath 2020, Carlsbad (United States), Series A	Developer of diagnostic solutions for Alzheimer's Disease	$8.41M	Stead Impact Ventures, Alzheimer's Drug Discovery	55/100
4th	Amydis Diagnostics 2013, San Diego (United States), Series A	Developer of diagnostics test for detection of Alzheimer's disease	$8.69M	NIA, Springboard Enterprises & 4 others	53/100
5th	Todos Medical 2009, Rehovot (Israel), Public	Developer of in vitro diagnostics for the detection of cancer and neurodegenerative disorders	-	Lincoln Park Capital, Yozma & 2 others	47/100
6th	DiamiR 2009, Monmouth Junction (United States), Funding Raised	Developer of minimally invasive diagnostic tests	-	NIA, HHS	45/100
7th	ADmit Therapeutics 2017, Barcelona (Spain), Series A	Provider of diagnostic services for early detection of Alzheimer's disease	$12.9M	Ship2B, Clave & 13 others	42/100
8th	Lucent Diagnostics 2023, Billerica (United States), Unfunded	Developer of a biomarker blood test for the diagnosis of Alzheimer's disease	-	-	40/100
9th	bioLOCKEY Healthworks 2023, Bengaluru (India), Seed	Developer of point-of-care diagnostics and novel biologics by Nanobody discovery platform	$478K	Pfizer, Pfizerindovation & 7 others	37/100
10th	Veravas 2017, Oakdale (United States), Series A	Provider of platform to manage sample preparation and diagnostic solutions	$25M	SeedFunders	37/100